1 / 3

Experimental Imaging Sciences Committee (EISC)

David Mankoff, MD, PhD Experimental Imaging Sciences Committee Chair Professor of Radiology University of Washington Seattle Cancer Care Alliance Seattle, Washington. Experimental Imaging Sciences Committee (EISC). Questions for Panel.

mirari
Download Presentation

Experimental Imaging Sciences Committee (EISC)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. David Mankoff, MD, PhD Experimental Imaging Sciences Committee Chair Professor of Radiology University of Washington Seattle Cancer Care Alliance Seattle, Washington Experimental ImagingSciences Committee(EISC)

  2. Questions for Panel • What logistical issues have you run into in the distribution of IND- • based PET agents for clinical trials? (ACRIN and others) • Production issues? • Regulatory, QC, etc? • Financial issues? • What do you see as the pathway for developing and testing new • compounds for PET imaging? • Non-proprietary compounds (e.g., FLT, FMISO, FES) • Proprietary compounds • Industry vs cooperative group/NCI trials? • How do you decide whether to bring a new compound into • commercial production? • What new compounds do you see on the horizon?

  3. Experimental ImagingSciences Committee(EISC) David Mankoff, MD, PhD Experimental Imaging Sciences Committee Chair Professor of Radiology University of Washington Seattle Cancer Care Alliance Seattle, Washington

More Related